Jagsonpal Pharmaceuticals may be a multibagger. Ace investors have big stakes in it

Jagsonpal Pharmaceuticals Limited is a Delhi-based pharmaceutical company. Founded in 1978, the Company has a proven track record of 40+ years of catering to the Indian pharmaceutical market. The Company has a robust portfolio of drugs focusing on Gynecology and Orthopedic segments.

Over the years, the Company has successfully built multiple brands that today hold market-leading position in respective segments. It has created a niche for itself in these value- accretive segments with 17 brands amongst Top 5 brands in the molecule category.

It has an extensive pan-India presence through its strong sales team of 900+ individuals. Infinity Holdings acquired a majority stake in the company and is a joint promoter of the company.

Jagsonpal Pharma has investments by Mukul Agrawal (₹28 Cr), Lincoln Coelho (₹19 Cr) & Sanjay Dangi (Authum) (₹23 Cr). M-Cap is ₹1600 Cr. Promoters hold 68%. Co is Debt-Free. RoCE is 18%. It has a portfolio of drugs focusing on Gynecology & Orthopedic with many leading brands